{"url_path":"/sec/mbot/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-022792-index.html","accession_number":"0001493152-26-022792","cik":"0000883975","ticker":"MBOT","issuer_name":"Microbot Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-022792-index.html","primary_entity_key":"0000883975","primary_entity_name":"Microbot Medical Inc."},"word_count":57,"has_tables":true,"body_markdown":"**Item\n5. Other Information.**\n\n \n\nDuring\nthe three months ended March 31, 2026, no director or officer, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934,\nas amended, of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”\nas each term is defined in Item 408(a) of Regulation S-K."}